MARSHALL MOHR - 28 Feb 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
Executive VP Global Business S
Signature
By: Donna Spinola For: Mohr, Marshall L
Issuer symbol
ISRG
Transactions as of
28 Feb 2024
Net transactions value
-$24,052,889
Form type
4
Filing time
29 Feb 2024, 19:17:15 UTC
Previous filing
27 Feb 2024
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $3,278,816 +13,530 +50% $242.34 40,407 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $5,210,139 -13,530 -33% $385.08 26,877 28 Feb 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $2,408,160 +13,530 +50% $177.99 40,407 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $5,210,139 -13,530 -33% $385.08 26,877 28 Feb 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $1,749,545 +10,500 +39% $166.62 37,377 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $4,043,345 -10,500 -28% $385.08 26,877 28 Feb 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $2,221,773 +12,750 +47% $174.26 39,627 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $4,909,776 -12,750 -32% $385.08 26,877 28 Feb 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $1,778,880 +12,750 +47% $139.52 39,627 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $4,909,776 -12,750 -32% $385.08 26,877 28 Feb 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $2,463,426 +22,500 +84% $109.49 49,377 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $5,630,044 -14,620 -30% $385.09 34,757 28 Feb 2024 Direct F1, F3
transaction ISRG Common Stock Options Exercise $1,791,850 +22,500 +65% $79.64 57,257 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $5,294,842 -13,750 -24% $385.08 43,507 28 Feb 2024 Direct F1, F4
transaction ISRG Common Stock Options Exercise $866,238 +11,250 +26% $77.00 54,757 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $2,641,659 -6,860 -13% $385.08 47,897 28 Feb 2024 Direct F1, F5
transaction ISRG Common Stock Options Exercise $1,919,750 +10,500 +22% $182.83 58,397 28 Feb 2024 Direct F1
transaction ISRG Common Stock Sale $4,043,345 -10,500 -18% $385.08 47,897 28 Feb 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $0 +2,253 +4.7% $0.000000 50,150 29 Feb 2024 Direct F6
transaction ISRG Common Stock Tax liability $441,486 -1,142 -2.3% $386.59 49,008 29 Feb 2024 Direct F6
transaction ISRG Common Stock Options Exercise $0 +1,003 +2% $0.000000 50,011 29 Feb 2024 Direct F6
transaction ISRG Common Stock Tax liability $196,774 -509 -1% $386.59 49,502 29 Feb 2024 Direct F6
holding ISRG Common Stock 100,353 28 Feb 2024 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -11,250 -100% $0.000000* 0 28 Feb 2024 Common Stock 11,250 $77.00 Direct F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -22,500 -100% $0.000000* 0 28 Feb 2024 Common Stock 22,500 $79.64 Direct F8
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -22,500 -100% $0.000000* 0 28 Feb 2024 Common Stock 22,500 $109.49 Direct F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -12,750 -100% $0.000000* 0 28 Feb 2024 Common Stock 12,750 $139.52 Direct F8
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,500 -100% $0.000000* 0 28 Feb 2024 Common Stock 10,500 $166.62 Direct F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -12,750 -100% $0.000000* 0 28 Feb 2024 Common Stock 12,750 $174.26 Direct F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -13,530 -100% $0.000000* 0 28 Feb 2024 Common Stock 13,530 $177.99 Direct F8
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,500 -100% $0.000000* 0 28 Feb 2024 Common Stock 10,500 $182.83 Direct F8
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -13,530 -100% $0.000000* 0 28 Feb 2024 Common Stock 13,530 $242.34 Direct F7
transaction ISRG Restricted Stock Units Options Exercise $0 -2,253 -100% $0.000000* 0 29 Feb 2024 Common Stock 2,253 $0.000000 Direct F9
transaction ISRG Restricted Stock Units Options Exercise $0 -1,003 -33% $0.000000 2,004 29 Feb 2024 Common Stock 1,003 $0.000000 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 15, 2024.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,620 shares sold at $383.85 to $384.82; 10,760 shares sold at $384.87 to $385.85; and 240 shares sold at $385.90 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,390 shares sold at $383.85 to $384.82; 10,116 shares sold at $384.87 to $385.79; and 244 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 1,574 shares sold at $383.85 to $384.73; 5,144 shares sold at $384.87 to $385.79; and 142 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F7 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F8 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F9 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.